NCT06750523View on ClinicalTrials.gov

Advancing Early Bone Health: New Frontiers for Osteoporosis Prevention

NAActive, not recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

May 17, 2023

Primary Completion Date

June 30, 2025

Study Completion Date

November 30, 2025

Conditions
Low-Risk Pregnant Women at Full-Term GestationHealthy Fetal PopulationHealthy Neonatal Population
Interventions
DIAGNOSTIC_TEST

Cord blood sampling

A cord blood sample will be taken at birth for analysis of oxidative stress markers, endocrine disruptors, and microRNAs.

DIAGNOSTIC_TEST

urine sampling

At one month of age, urine samples will be collected from newborns to analyze oxidative stress markers and endocrine disruptors.

BEHAVIORAL

Life style questionnaire

At the time of enrollment, mothers will complete a specialized questionnaire designed to assess potential exposure to endocrine disruptors (EDCs) through diet, clothing, and the use of cosmetics and detergents.

Trial Locations (2)

43126

Azienda Ospedaliero-Universitaria di Parma, Parma

98125

"Azienda Ospedaliero Universitaria Gaetano Martino di Messina", Messina

All Listed Sponsors
collaborator

Azienda Ospedaliero-Universitaria di Parma

OTHER

collaborator

"Azienda Ospedaliera Universitaria Policlinico G. Martino"

OTHER

lead

University of Parma

OTHER